Published at 05:29 (GMT) 21 Apr
Telegraph: British drug group AstraZeneca said to have rebuffed approach from America's Pfizer that would create £150bn behemoth.
British pharmaceuticals group AstraZeneca has received a preliminary approach from US peer Pfizer about a potential deal that could create an industry giant worth more than £150bn.
Talks are said to have taken place between Pfizer and Astra about a possible £60bn acquisition of the FTSE 100-listed company - though it is unclear whether the discussions are still live. Any deal between Pfizer, which makes anti-impotence drug Viagra and is valued at $193bn (£115bn), and Astra would create one the world's top 10 companies by market value. Astra, whose shares closed up 23 at £37.81½ on Thur, has a mkt cap of £47.7bn.
On FX, focus on the above pharma talks - though unclear whether it is still "live" as reported above. But could nevertheless see support for GBP/USD. GBP/USD at 1.6799-02, focus on 4-year 6-month highs of 1.6840-43, highest since November 2009. Eye any UK/US Pharma giants, corporate demand and speculators, Asian real money demand. Bids at 1.6750-60, offers 1.6810-20, weak stops above 1.6820-25. Then above 1.6850. Thin markets with most of Europe/UK away on Easter Monday.
EUR/GBP at 0.8222-25, eye break of 0.8200, given speculation of M+A demand, less hawkish BoE vs still dovish ECB. Offers 0.8240-50. WL
Recommended Content
Editors’ Picks
EUR/USD holds gains near 1.0650 amid risk reset
EUR/USD is holding onto its recovery mode near 1.0650 in European trading on Friday. A recovery in risk sentiment is helping the pair, as the safe-haven US Dollar pares gains. Earlier today, reports of an Israeli strike inside Iran spooked markets.
GBP/USD recovers toward 1.2450 after UK Retail Sales data
GBP/USD is rebounding toward 1.2450 in early Europe on Friday, having tested 1.2400 after the UK Retail Sales volumes stagnated again in March, The pair recovers in tandem with risk sentiment, as traders take account of the likely Israel's missile strikes on Iran.
Gold price defends gains below $2,400 as geopolitical risks linger
Gold price is trading below $2,400 in European trading on Friday, holding its retreat from a fresh five-day high of $2,418. Despite the pullback, Gold price remains on track to book the fifth weekly gain in a row, supported by lingering Middle East geopolitical risks.
Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium
Bitcoin price shows no signs of directional bias while it holds above $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research.
Geopolitics once again take centre stage, as UK Retail Sales wither
Nearly a week to the day when Iran sent drones and missiles into Israel, Israel has retaliated and sent a missile into Iran. The initial reports caused a large uptick in the oil price.